Doctoral projects

Programs that offer doctoral opportunities:

Clinical Pharmacy
The doctoral program "Clinical Pharmacy" is an interdisciplinary institution at the University Hospital of Munich. The doctoral projects that are being worked on as part of the program deal with issues relating to increasing the Drug therapy safety. The aim is to make a significant contribution to increasing patient safety in a wide range of diseases. Another aim is to strengthen the scientific database in the field of applied clinical pharmacy.

FöFoLe
The aim is to train medical and dental students for research in medicine. This program was first established in July 2001 and promotes the training (18 months) of particularly talented and scientifically interested students of human medicine and dentistry for research in medicine. Approximately 42 students are admitted for a period of 18 months.

SFB 1064
The SFB 1064 focuses on fundamental aspects of chromatin dynamics. It aims at understanding principles and mechanisms that endow chromatin organization with diversity, flexibility and plasticity to respond to environmental and developmental cues. CRC research strives for an integrated understanding of chromatin structure and function from atomic resolution, via molecular interactions and mechanism to finally reach the microscopically resolvable structures of nuclei in physiological settings.

SFB 1054
The SFB 1054 will explore control and plasticity of cell-fate decisions in the immune system, identify input signals that determine stability and flexibility of differentiation, and characterize the molecular basis for how these signals are decoded.

POKAL
The Research Training Group "Predictors and clinical outcomes of depressive illnesses in primary care (POKAL)" (RTG 2621) is concerned with the means by which depression can be treated in primary care. Primary care Recognizing and treating depression in old age earlier and more safely. The DFG is funding an innovative research and training program at the Munich Universities of Excellence LMU and TUM.

GRK 2338
The Research Training Group "Targets in Toxicology - Deciphering Therapeutic Targets in Lung Toxicology" is a structured Ph.D. program which brings together twelve research partners in the Munich region. Principal investigators from the LMU Munich, Helmholtz Zentrum München, Technische Universität München, and the Bundeswehr Institute of Pharmacology and Toxicology have teamed up to acquire an in-depth mechanistic understanding of toxic lung injury and to develop the new concept of "precision toxicology" in acute and chronic toxic lung injury.

MvPI Infection research
The Max von Pettenkofer Institute (MvPI) of the LMU offers the structured international doctoral program "Infection Research on Human Pathogens@MvPI" under the umbrella of the MMRS. This program combines the completion of an individual doctoral project (doctoral thesis) in the field of infection research (with a focus on microbiology/bacterial pathogens, microbiota research, virology and infection immunology) with program-specific framework courses for in-depth and comprehensive thematic rounding off in central and current topics of infection research as well as further practical courses and offers on transferable skills.

T-OP: Training Network for Optimizing Adoptive T cell Therapy of Cancer
Over the last few years, immunotherapy - using a patient's own immune system to fight tumors - has emerged as an important complement to standard treatments. Adoptive T cell therapy (ACT) is the collection and transformation of the patient's own T cells to treat cancer. T-OP targets a pioneering research question: how do cytokines influence the therapeutic outcome of ACT products? T-OP brings together interdisciplinary and cross-sectorial teams spanning large and small-sized companies as well as experts in different aspects of cell therapy, immunology, protein engineering and bioinformatics. T-OP will train 15 Early Stage Researchers (ESR), enabling them to develop efficient therapeutic solutions and to tackle economic opportunities.